SG Americas Securities’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Buy	60,044 +26,956	+81%	+$801K	﹤0.01%	1660
2025 Q4	$1.03M	Sell	33,088 -29,030	-47%	-$796K	﹤0.01%	1992
2025 Q3	$1.34M	Buy	62,118 +49,981	+412%	+$901K	﹤0.01%	1211
2025 Q2	$170K	Sell	12,137 -19,835	-62%	-$269K	﹤0.01%	2370
2025 Q1	$431K	Buy	31,972 +887	+3%	+$15.1K	﹤0.01%	1896
2024 Q4	$596K	Buy	31,085 +14,644	+89%	+$318K	﹤0.01%	1182
2024 Q3	$374K	Sell	16,441 -29,615	-64%	-$484K	﹤0.01%	1951
2024 Q2	$599K	Buy	+46,056	New	+$638K	﹤0.01%	1573
2024 Q1	–	Sell	-40,588	Closed	-$884K	–	3478
2023 Q4	$884K	Sell	40,588 -62,079	-60%	-$980K	0.01%	1090
2023 Q3	$1.57M	Buy	102,667 +61,676	+150%	+$1.18M	0.02%	911
2023 Q2	$975K	Buy	40,991 +30,732	+300%	+$788K	0.01%	1067
2023 Q1	$261K	Buy	10,259 +3,690	+56%	+$118K	﹤0.01%	2217
2022 Q4	$192K	Sell	6,569 -1,713	-21%	-$39.5K	﹤0.01%	2227
2022 Q3	$170K	Buy	+8,282	New	+$149K	﹤0.01%	2446
2019 Q1	–	Sell	-6,622	Closed	-$301K	–	3668
2018 Q4	$301K	Buy	6,622 +445	+7%	+$25.7K	﹤0.01%	2165
2018 Q3	$517K	Buy	+6,177	New	+$583K	﹤0.01%	2097
2017 Q4	–	Sell	-1,819	Closed	-$250K	–	3682
2017 Q3	$250K	Buy	+1,819	New	+$306K	﹤0.01%	2400